Hedge Fund - Platinum Management
Navidea Biopharmaceuticals Inc. (NAVB)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2016 - Q1 (2016-03-31) | $14,711,000 | 89.51% | 778,797.3 | $19.24 |
| 2 | 2015 - Q4 (2015-12-31) | $4,588,000 | 36.83% | 172,498.45 | $34.73 |
| 3 | 2015 - Q3 (2015-09-30) | $28,970,000 | 93.08% | 635,316.2 | $37.71 |
| 4 | 2015 - Q2 (2015-06-30) | $19,630,000 | 85.69% | 609,616.35 | $29.05 |
| 5 | 2015 - Q1 (2015-03-31) | $18,213,000 | 62.73% | 572,741.55 | $33.84 |
| 6 | 2014 - Q4 (2014-12-31) | $27,601,000 | 47.45% | 730,180.15 | $27.50 |
| 7 | 2014 - Q3 (2014-09-30) | $19,861,000 | 4.55% | 752,321.55 | $26.47 |
| 8 | 2014 - Q2 (2014-06-30) | $22,075,000 | 3.13% | 745,781.55 | $32.34 |
| 9 | 2014 - Q1 (2014-03-31) | $26,036,000 | 12.29% | 703,671.55 | $37.93 |
| 10 | 2013 - Q4 (2013-12-31) | $13,549,000 | 19.75% | 518,766.45 | $39.13 |
| 11 | 2013 - Q3 (2013-09-30) | $24,807,000 | 13.33% | 468,063.8 | $58.29 |
| 12 | 2013 - Q2 (2013-06-30) | $0 | 0% | 0 | $49.93 |
| 13 | 2013 - Q1 (2013-03-31) | $20,852,000 | 42.02% | 384,725.85 | $60.46 |
| 14 | 2012 - Q4 (2012-12-31) | $22,667,000 | 33.67% | 400,479.45 | $53.35 |
| 15 | 2012 - Q3 (2012-09-30) | $19,051,000 | 17.79% | 346,381.1 | $75.11 |
| 16 | 2012 - Q1 (2012-03-31) | $14,345,000 | 14% | 260,829.8 | $60.53 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:20.0000 on 2019-04-26